From the Community to the Bench and Back Again: The Value of Patient and Community Engagement in Cancer Research

被引:6
|
作者
Leader, Amy E. [1 ,2 ]
Aplin, Andrew E. [2 ,3 ]
机构
[1] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA
关键词
HEALTH;
D O I
10.1158/2159-8290.CD-21-0693
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Currently, patients and community members have more frequent interaction with clinical and population scientists than basic scientists, leading to gaps in their engagement across the cancer research continuum. Engaging patients and community members in all types of cancer research can bring personal experiences and societal factors to the forefront, informing scientists about these concerns and leading to research that is more responsive to patient and community needs. Engaging patients with cancer and community members as partners in research helps ensure that the scientific evidence generated is useful to patients and-more importantly-trusted by patients. This bidirectional engagement between patients/community members and research investigators fosters a collaborative and ethical foundation for scientific discovery. Although community-engaged research has been in existence for decades, more recent attention by national organizations to embed patients with cancer and community members into the research process has accelerated the importance of these efforts. Here, we describe the importance of patient and community engagement (PCE) in cancer research. We outline key principles in undertaking PCE in cancer research, provide a framework for PCE throughout the cancer research continuum, review metrics for evaluating the effectiveness of PCE in cancer research, and share opportunities for PCE in cancer research going forward.
引用
收藏
页码:2135 / 2138
页数:4
相关论文
共 50 条
  • [1] Quandaries in patient and community engagement in research
    Westfall, John M.
    Zittleman, Linda K.
    [J]. FAMILY PRACTICE, 2017, 34 (03) : 253 - 255
  • [2] From bench to bedside and back again: translational research in autoinflammation
    Dirk Holzinger
    Christoph Kessel
    Alessia Omenetti
    Marco Gattorno
    [J]. Nature Reviews Rheumatology, 2015, 11 : 573 - 585
  • [3] From bench to bedside and back again: translational research in autoinflammation
    Holzinger, Dirk
    Kessel, Christoph
    Omenetti, Alessia
    Gattorno, Marco
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2015, 11 (10) : 573 - 585
  • [4] Defining Wilson Disease Phenotypes: From the Patient to the Bench and Back Again
    Ferenci, Peter
    Roberts, Eve A.
    [J]. GASTROENTEROLOGY, 2012, 142 (04) : 692 - 696
  • [5] From bench to bedside and back again?
    不详
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 170 (12) : 1765 - 1765
  • [6] From bedside to bench and back again
    Collier, Roger
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (06) : E323 - E324
  • [7] From the bench to the farm and back again
    Canton, Johnathan
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2024,
  • [8] From bench to business and back again
    Wilan, Ken
    [J]. CELL, 2007, 131 (02) : 211 - 213
  • [9] Patient engagement in melanoma research: from bench to bedside
    Tivey, Ann
    Huddar, Prerana
    Shotton, Rohan
    Cheese, Imogen
    Daniels, Susanna
    Lorigan, Paul
    J Lee, Rebecca
    [J]. FUTURE ONCOLOGY, 2021, 17 (28) : 3705 - 3716
  • [10] Translational Research in Retinopathy of Prematurity: From Bedside to Bench and Back Again
    Arima, Mitsuru
    Fujii, Yuya
    Sonoda, Koh-Hei
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (02) : 1 - 27